Table 2.

Plasma pharmacokinetic parameters for MPO after intravenous or subcutaneous administration to normal rhesus monkeys

Pharmacokinetic Parameters Rhesus
Intravenous* 
 Dose (μg/kg)  10    
Half-lives (h)  
 First 0.533 ± 0.051  
 Second  25.3 ± 14.0  
 Clearance (mL/min/kg)  0.415 ± 0.070  
 VC (L/kg) 0.0220 ± 0.0026  
 VSS (L/kg) 0.0706 ± 0.0481  
Subcutaneous* 
 Dose (μg/kg) 30    
 CMAX (ng/mL)  97.4 ± 29.1 
 TMAX (h)  3.3 ± 1.3  
 AUC ([ng/mL]h) 806 ± 368  
 Bioavailability (%)  62.5 
Pharmacokinetic Parameters Rhesus
Intravenous* 
 Dose (μg/kg)  10    
Half-lives (h)  
 First 0.533 ± 0.051  
 Second  25.3 ± 14.0  
 Clearance (mL/min/kg)  0.415 ± 0.070  
 VC (L/kg) 0.0220 ± 0.0026  
 VSS (L/kg) 0.0706 ± 0.0481  
Subcutaneous* 
 Dose (μg/kg) 30    
 CMAX (ng/mL)  97.4 ± 29.1 
 TMAX (h)  3.3 ± 1.3  
 AUC ([ng/mL]h) 806 ± 368  
 Bioavailability (%)  62.5 
*

Values are the mean (±SEM) for 3 monkeys.

VC and VSS are the apparent central compartment and steady state volumes of distribution, respectively.

Values are calculated from 0 to 24 hours for monkeys.

Close Modal

or Create an Account

Close Modal
Close Modal